Nektar Therapeutics
NKTR
NKTR
348 hedge funds and large institutions have $5.48B invested in Nektar Therapeutics in 2019 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 140 increasing their positions, 109 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.11% less ownership
Funds ownership: 6.36% → 6.24% (-0.11%)
42% less call options, than puts
Call options by funds: $28.1M | Put options by funds: $48.5M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
348
Holding in Top 10
1
Calls
$28.1M
Puts
$48.5M
Top Buyers
| 1 | +$74.6M | |
| 2 | +$21.5M | |
| 3 | +$14.2M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$13.8M |
| 5 |
State Street
Boston,
Massachusetts
|
+$10.4M |
Top Sellers
| 1 | -$186M | |
| 2 | -$19.3M | |
| 3 | -$15.6M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$13.8M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$10.6M |